New Product Newswire
FDA Roundup: Myhibbin for Prophylaxis of Organ Rejection, Insulin App Recall
Check out important updates from the FDA for the week of May 6.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Delays Decision on Moderna’s RSV Vaccine
The federal agency said the delay was due to administrative constraints and did not cite any vaccine safety, efficacy or quality issues.
FDA Approves Oral Treatment for Postpartum Depression
Last August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.
FDA Advisory Committee Will Soon Meet to Discuss MDMA-Assisted Therapy for PTSD
The Psychopharmacologic Drugs Advisory Committee will meet June 4 to review a new drug application from Lykos Therapeutics.
FDA Approves Myhibbin for Prophylaxis of Organ Rejection in Adult, Pediatric Transplant Recipients
Mycophenolate mofetil oral suspension is the only FDA-approved ready-to-use liquid formulation.